The PAX8 / PPAR&ggr; Fusion Oncogene as a Potential Therapeutic Target in Follicular Thyroid Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|4|3|221-234

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.4, Iss.3, 2004-09, pp. : 221-234

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR-&ggr; Agonists as Regulators of Microglial Activation and Brain Inflammation

By  

Current Pharmaceutical Design, Vol. 12, Iss. 1, 2006-01 ,pp. : 93-109

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR)&bgr; /&dgr;: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

By  

Current Molecular Pharmacology, Vol. 2, Iss. 1, 2009-01 ,pp. : 46-55

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase as a Therapeutic Target for Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 661-670

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-H2AX as a Therapeutic Target for Improving the Efficacy of Radiation Therapy

By  

Current Cancer Drug Targets, Vol. 6, Iss. 3, 2006-05 ,pp. : 197-205

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Elements of Apoptosis-Regulating Pathways in Follicular Thyroid Cells: Mining for Novel Therapeutic Targets in the Treatment of Thyroid Carcinoma

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 187-198

Bentham Science Publishers

Access to resources Recommend Favorite